Introduction
In a recent paper we have reported an interaction between ACPj (Erythrocyte acid phosphatase EC 3.1.3.2.) and ADA (Adenosine deaminase EC 3.5.4.4.) in relation to neonatal hyperbilirubinemia. The incidence of jaundice was much higher among newborn of ACPi phenotype BA carrying ADA 2 allele (41.7%) than among other infants (7.5%) [3] . We have now studied a new series of infants from another population: the data confirm that ACPi phenotype BA carrying ADA 2 allele has a very high risk of clinically relevant neonatal jaundice.
It is likely that both environmental and genetic factors influence the severity of "physiologic jaundice of newborn". As in many pathologic situations in which a multifactorial inheritance is presumed, research should be directed toward those factors which determine the "normal variability" of biochemical and physiological parameters. Human genetic polymorphisms are therefore the most important candidates for this kind of investigations. ACPi is an enzyme found in the cytoplasm of many tissues besides red blood cells. It is genetically distinct from acid phosphatases found in lysosomes and is polymorphic with three codominant alleles (P A , P B and P c ) at an autosomal locus [11, 12, 20] . ACPi probably acts in vivo as a flavin mononuclectide phosphatase [14, 15, 17] . It may therefore modulate Krebs-cycle activity and other important enzymes such as glutathione reductase, a flavoenzyme which exert a key role in the maintenance of red cell integrity [17] . Enzymatic activity of ACPi is modulated (activated or inhibited) by purines and inhibited by folic acid. The most important aspect of these findings is the fact that in the quantitative variation of ACPi enzyme activity, the contribution of the alloenzymes increases in the order P A < P B < P c [12] whereas with the effects on purine and folic acid modulation, the alloenzyme contribution is ranked either P c < P A < P B or P B < P A < P c . This difference in ranking indicates that the two types of activity variation represent independent effects [14] .
The association previously reported [5, 6, 8] between CA phenotype and neonatal hyperbilirubinemia has been tentatively explained by the fact that activation of CA by adenine is stronger as compared to other ACPi genotypes. This would cause a reduced availability of flavin cofactors (figure 1) and a lower activity of the flavo-enzyme glutathione reductase which in turn may be reflected in a reduced red cell stability [14] . Since flavoenzymes have a central role in metabolism, modulation of coenzyme levels may have importance in many developmental processes which may influence bilirubin metabolism. Recent observations by our group seem to give support to this conjecture [2, 4] . ADA is a polymorphic enzyme which catalizes the deamination of adenosine to inosine. Its synthesis is controlled by an autosomal locus with two codominant alleles ADA 1 and ADA
2
. The enzymatic activity decreases in the order ADA 1 > ADA 2 [1, 9, 19] . The study of possible interactions between ACPi and ADA was suggested by the observation that while adenosine does not show appreciable effects of ACPi activity, inosine, on the contrary, is a relatively strong activator [14] .
Material and methods

Infants from the population of Penne
Penne is a small town in the East Side of Southern Italy. It is located in a rural area, at a distance of about two hundred kilometers from Rome. The population is very homogeneous and immigration is practically absent. These people are probably the direct descendants of the ancient Italic population called "VESTINI".
A sample of 56 children treated by phototherapy during the neonatal period (53% of infants observed in four years) were studied. All children were born at term and weighted 2500 grams or more. Phototherapy was started at bilirubin level of 12 mg/dl. The proportion of full term infants treated by phototherapy is about 15% in this population.
A control sample of 141 newborn infants without clinically relevant neonatal jaundice were also studied.
Newborn infants from the population of Rome
This sample has been already reported in a previous paper [3] . Two consecutive series of infants, born at term, weighting 2500 gr or more and compatible with their mothers in ABO and Rh systems, were studied. Both ADA and ACP t phenotypes were determined in 225 infants. Twenty one (9.33%) were treated by phototherapy. In these subjects, therapy was started at bilirubin levels greater than 12 mg/dl. ACPi and ADA phenotypes were determined by starch gel electrophoresis [12, 19] on umbilical cord blood (Rome) or venous blood (Penne). Table I shows the sample distribution of some relevant variables in infants with neonatal jaundice. In the sample from Penne, maternal age distribution is shifted towards extreme values. Tables II and III and figure 2 show that in both populations BA phenotype carrying ADA 2 allele is associated with a very high incidence of clinically relevant neonatal jaundice. However, besides this striking similarity of the ACPi by ADA interaction in relation to neonatal jaundice the data also show differences between the two populations. In fact ACPi phenotype BA not carrying ADA 2 shows an incidence of jaundice much higher in the pop- ulation of Penne than in the population of Rome. These differences may be due: (i) to ethnics background, (ii) to differences in the clinical approach especially in the administration of phototherapy, and (iii) to the possibility that jaundiced infants excluded for sampling have slightly different clinical characteristics as compared to infants included in the study. 
Results
Discussion
The present data make it extremely unlikely that the observed combined effect of ACPi and ADA phenotypes on the incidence of neonatal jaundice may be due to sampling chance phenomena. Since the population of Penne is homogeneous, stratification can be reasonably excluded.
The positive association of jaundice with phenotype CA previously reported by our group may be explained assuming that, since CA has a relatively high activity, flavin cofactors and glutathione reductase activity are reduced. This in turn would cause a reduction of RBC survival and an increase of bilirubin load. In subjects carrying ADA 2 , however, the highest incidence of neonatal jaundice is observed in ACPi phenotype BA. Since ACPi BA has a low enzymatic activity and probably a relatively high levels of flavin cofactors, some other mechanism must be assumed in order to explain the association. ADA 2 carriers produce less inosine as compared to ADA 1 subjects and therefore ACP t activity may be generally lower in ADA 2-1 than in ADA 1. ACPj phenotype BA in the presence of ADA 2 might attain very low enzymatic activities and in turn flavoenzymes and related metabolic pathways might have high levels of activity. It is known that microsomal heme oxigenase catalyses the oxidation of heme at the oc-methene bridge to form biliverdin; this step is subsequently coupled with soluble NADPH-dependent biliverdin reductase to form bilirubin [7, 16, 21] . Concentration of cofactors produced by metabolic pathways involving flavoenzymes may be rate-limiting for the heme-oxigenase complex and for the production of bilirubin in the newborns. Heme oxigenase activity and production of endogeneous CO in newborns should be analysed in relation to ACPi and ADA phenotype in order to give support to our conjecture.
Ethnic factors may affect the severity of physiologic jaundice in full-term compatible newborns [10, 13] . Table IV shows that the incidence of clinically significant jaundice (serum bilirubin 10 -12 mg/dl) in ABO compatible newborns is much lower in Negro than in White population. In Negro populations the frequency of BA-ADA 2-1 phenotype is about one fifth of that observed in Whites. Assuming that interactions similar to those observed in Italian populations are also acting in the genetic background of Blacks, from the data in table IV one can calculate that more than one third of the difference in the incidence of neonatal jaundice between the two ethnic groups may be explained by the difference in the frequency of ACPi BA-ADA 2-1 genotype. The practical absence of ACPi phenotype CA in Blacks may also contribute to the low incidence of jaundice in this ethnic group.
Genes for ACPi and ADA are on chromosomes 2 and 20 respectively; therefore, no linkage effects are involved in the interaction between these polymorphisms.
The possibility that effects on jaundice may be due to genes linked to ACPi and/or ADA cannot be excluded at present. However, since the functions of ACPi and ADA suggest plausible biochemical mechanisms we would favour a direct involvement of ACPi and ADA in the phenomenon presently described.
It is likely that metabolic variability due to enzyme polymorphism may significantly contribute to modulation of bilirubin metabolism in the critical phase of adaptation to extrauterine life. Enzyme of purine nucleotide metabolism (including ADA), ACPi and flavoenzymes may represent a polygenic complex influencing bilirubin levels in the first few days of life and probably also other developmental variables.
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